Summary
Up to now only 30 to 40% of patients who die suddenly can be identified as likely candidates before the event. Risk factors in these asymptomatic subjects include a familial history of coronary artery disease, high blood cholesterol levels, hypertension, smoking and, more importantly, an abnormal ECG at rest or during exercise. The predictive value of these abnormalities is too low to justify more detailed clinical investigations in most of these asymptomatic subjects. Exceptions might be the group of patients with multiple risk factors and competitive sportsmen.
Sudden cardiac death is a well known complication in patients with hypertrophic and dilated cardiomyopathy. Risk factors in hypertrophic cardiomyopathy include a familial history of this disease, syncope and increasing age. Furthermore, in the adult, the presence of nonsustained episodes of ventricular tachycardia during Holter monitoring seems to indicate an increased risk of sudden cardiac death. In idiopathic dilated cardiomyopathy, the presence of frequent episodes of ventricular pairs and/or episodes of ventricular tachycardia during Holter monitoring, together with a reduced left ventricular ejection fraction, characterises the patient at risk of sudden cardiac death. In patients with coronary artery disease, the patient at risk of sudden cardiac death can be identified by investigating the following: coronary anatomy; global and regional left ventricular function; the presence of ischaemia during rest and/or exercise; the presence of late potentials, by means of the signal-averaged ECG; the presence of spontaneous ventricular arrhythmias (especially sustained and nonsustained ventricular tachycardia); and the results of electrophysiological testing. On the basis of these investigations, 3 subgroups can be distinguished: patients at low risk, medium risk, and high risk of sudden cardiac death.
Similar content being viewed by others
References
Ahnve S, Gilpin E, Henning H, Curtis G, Collins D, et al. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. American Journal of Cardiology 58: 872–878, 1986
Chiang BN, Perlman LV, Fulton M, Ostrander LD, Epstein FH. Predisposing factors in sudden cardiac death in Tecumseh, Michigan: a prospective study. Circulation 41: 31–37, 1970
Das SK, Morady F, DiCarlo L, Baerman J, Krol R, et al. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. American Journal of Cardiology 58: 998–1000, 1986
Dunica S, Coumel P. Incidence and mechanisms of sudden death in patients with left ventricular dysfunction. Heart Failure 6: 244–255, 1986
Dwyer EM, Greenberg H, Case RB and the Multicenter Postinfarction Research Group: association between transient pulmonary congestion during acute myocardial infarction and high incidence of death in six months. American Journal of Cardiology 58: 900–905, 1986
Friedman M, Manwaring JH, Roseman RH. Instantaneous exercise and sudden death. Journal of the American Medical Association 225: 1319–1323, 1972
Greene HL, Richardson DW, Barker AH, Roden DM, Capone RJ, et al. and the CAPS investigators. Classification of death after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot Study). American Journal of Cardiology 63: 1–6, 1989
Kuck KH, Kunze KP, Geiger M, Costard A, Schlüter M. Programmed electrical stimulation in patients with hypertrophic cardiomyopathy: results in patients with and without cardiac arrest or snycope. Cardiac Arrhythmias 22: 367–376, 1987
Maron BJ, Roberts WC, Edwards JE, McAllister HA, Epstein SE. Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients without functional limitations. American Journal of Cardiology 41: 803, 1978
Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 65: 1388–1394, 1982
Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance in 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophie cardiomyopathy: a prospective study. American Journal of Cardiology 48: 252–257, 1981
McKenna WJ, Deanfield J, Faruqui A, England D, Oakley CM, et al. Prognosis in hypertrophie cardiomyopathy. American Journal of Cardiology 47: 532–538, 1981a
McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, et al. Arrhythmia in hypertrophie cardiomyopathy. I. Influence on prognosis. British Heart Journal 46: 168–172, 1981b
McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, et al. Amiodarone for long term management of patients with hypertrophie cardiomyopathy. American Journal of Cardiology 54: 802–810, 1984
Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. American Journal of Cardiology 53: 902–907, 1984
Meinertz T, Treese N, Kasper W, Geibel A, Hofmann T, et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. American Journal of Cardiology 56: 337–341, 1985
Menapace FJ, Hammer WJ, Rityer TF. Left ventricular size in competitive weight lifters: an echocardiographic study. Medicine and Science in Sports and Exercise 3: 141–144, 1982
Morales AR, Romanelli R, Boucek RJ. The neural LAD coronary artery, strenuous exercise and sudden death. Circulation 62: 230, 1980
Moss AJ, Bigger TJ, Case RB, Gillespie JA, Goldstein RE, et al. The multicenter postinfarction research group: risk stratification and survival after myocardial infarction. New England Journal of Medicine 390: 331–336, 1983
Munschek H. Ursachen des akuten Todes beim Sport in der Bundesrepublik. Sportarzt und Sportmedizin 5: 133, 1977
Newman H, Sugrue DD, Oakley CM, Goodwin JF, McKenna WJ. Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographie study. Journal of the American College of Cardiology 5: 1064–1074, 1985
Opie LH. Sudden death and sports. Lancet 3: 263–267, 1975
Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72: 681–685, 1985
Pedoe HDT. Predictability of sudden death from resting electrocardiogram: effect of previous manifestations of coronary heart disease. British Heart Journal 4040: 630–635, 1978
Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, et al. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 70: 451–456, 1984
Siscovick D, Weiss N, Fletcher R, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. New England Journal of Medicine 311: 874–876, 1984
Thompson PD, Stern MP. Death during jogging or running. Journal of the American Medical Association 242: 1265–1270, 1979
Vuori I, Makarainen M, Lasselainen A. Sudden death and physical activity. Cardiology 63: 287–295, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meinertz, T., Hofmann, T. & Zehender, M. Can We Predict Sudden Cardiac Death?. Drugs 41 (Suppl 2), 9–15 (1991). https://doi.org/10.2165/00003495-199100412-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199100412-00004